Screening of atrophic gastritis and gastric cancer using serum pepsinogen, gastrin-17 and Helicobacter pylori IgG antibodies

Chinese Journal of Gastroenterology

Volumn 11, Issue 7, 2006, Pages 388-394

  Cao, Qin ^a   Ran, Zhihua ^a   Xiao, Shudong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Gastrins; Gastritis, atrophic; Helicobacter pylori IgG antibodies; Pepsinogens; Stomach neoplasms

Indexed keywords

BACTERIUM ANTIBODY; BIOLOGICAL MARKER; GASTRIN 17; IMMUNOGLOBULIN G ANTIBODY; PEPSINOGEN I; PEPSINOGEN II;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; ATROPHIC GASTRITIS; BLOOD SAMPLING; CANCER INCIDENCE; CANCER SCREENING; CANCER STAGING; CHINA; CHRONIC GASTRITIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIET RESTRICTION; DUODENUM ULCER; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; ROC CURVE; SENSITIVITY AND SPECIFICITY; STOMACH ANTRUM; STOMACH CANCER; STOMACH ULCER; TISSUE DISTRIBUTION;

EID: 33750177629     PISSN: 10087125     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Version 1.0. IARC Cancer Base No. 5. Lyon: IARC Press, 2001.
2. Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer, 1985, 35: 173-177.
3. Koga M, Miyakawa K, Ikeda S. Annual Report of Gastroenterological Mass Survey in Japan, 2002. Tokyo: Japanese Society of Gastroenterology Mass Survey. 2004.
4. Sipponen P, Ranta P, Helske T, Kaariainen I, Maki T, Linnala A, Suovaniemi O, Alanko A, Harkonen M. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol, 2002, 37: 785-791.
5. Sipponen P, Harkonen M, Alanko A, Suovaniemi O. Diagnosis of atrophic gastritis from a serum sample. Clin Lab, 2002, 48: 505-515.
6. Vaananen H, Vauhkonen M, Helske T, Kaariainen I, Rasmussen M, Tunturi-Hihnala H, Koskenpato J, Sotka M, Turunen M, Sandstrom R, Ristikankare M, Jussila A, Sipponen P. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I : a multicentre study. Eur J Gastroenterol Hepatol, 2003, 15: 885-891.
7. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, Komoto K, Tanaka S, Kajiyama G. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol, 1998, 93: 1090-1096.
8. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol, 2003, 98:735-739.
9. Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut, 1999, 44: 693-697.
10. Kikuchi S, Kurosawa M, Sakiyama T, Tenjin H, Miki K, Wada O, Inaba Y. Long-term effect of Helicobacter pylori infection on serum pepsinogens. Jpn J Cancer Res, 2000, 91:471-476.
11. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol, 1996, 20: 1161-1181.
12. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res, 1992, 52: 6735-6740.
13. Namekata T, Miki K, Kimmey M, Fritsche T, Hughes D, Moore D, Suzuki K. Chronic atrophic gastritis and Helicobacter pylori infection among Japanese Americans in Seattle. Am J Epidemiol, 2000, 151: 820-830.
14. Forman D. Helicobacter pylori infection: a novel risk factor in the etiology of gastric cancer. J Natl Cancer Inst, 1991, 83: 1702-1703.
15. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med, 1991, 325: 1127-1131.
16. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med, 1991, 325: 1132-1136.
17. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. In: IARC monographs on the evaluation of carcinogenic risks to humans. Lyon: IARC Monograph, 1994. 218-220.
18. 13C-urea breath test, and serology. Scand J Gastroenterol, 2000, 35: 138-141.
19. Samloff IM. Pepsinogens I and II : purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology, 1982, 82: 26-33.
20. Sitas F, Smallwood R. Jewell D. Millard PR, Newell DG, Meuwissen SG, Moses S. Zwiers A, Forman D. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis. Cancer Epidemiol Biomarkers Prev, 1993, 2: 119-123.
21. Wu KC, Li HT, Qiao TD, Li CN, Ji WS, Tian FQ, Wang X, Wang BL, Miao JY, Ding J, Fan DM. Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen. Chin J Dig Dis, 2004, 5: 22-27.
22. Ito M, Haruma K, Kamada T, Mihara M, Kim S, Kitadai Y, Sumii M, Tanaka S. Yoshihara M, Chayama K. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther, 2002, 16: 1449-1456.
23. Lorente S, Doiz O, Trinidad Serrano M, Castillo J, Lanas A. Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells. Gut, 2002, 50: 13-18.
24. Chinese source. 1991, 20: 84-86.
25. Ohata H, Oka M, Yanaoka K, Shimizu Y, Mukoubayashi C, Mugitani K, Iwane M, Nakamura H, Tamai H, Arii K, Nakata H, Yoshimura N, Takeshita T, Miki K, Mohara O, Ichinose M. Gastric cancer screening of a high-risk population in Japan using serum pepsinogen and barium digital radiography. Cancer Sci, 2005, 96: 713-720.
26. Chinese source. 2003, 9: 347-352.
27. Xiao SD, Jiang SJ, Shi Y, Zhang DZ, Hu YB, Liu WZ, Yuan JM. Pernicious anemia and type A atrophic gastritis in the Chinese. Chin Med J (Engl), 1990, 103: 192-196.
28. Song DH, Rana B, Wolfe JR, Crimmins G, Choi C, Albanese C, Wang TC, Pestell RG, Wolfe MM. Gastrin-induced gastric adenocarcinoma growth is mediated through cyclin D1. Am J Physiol Gastrointest Liver Physiol, 2003, 285: G217-G222.
29. Wang TC, Dangler CA, Chen D. Goldenring JR, Koh T, Raychowdhury R, Coffey RJ, Ito S, Varro A, Dockray GJ, Fox JG. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology, 2000, 118: 36-47.
30. Chinese source. 2002, 19: 32-34.
31. Chinese source. 1993, 13: 69-72.
32. Nduduba DA, Rotimt O, Otegbeye FM. Helicobacter pylori and the pathogenesis of gastroduodenal disease: implications for the management of peptic ulcer disease. Niger Postgrad Med J, 2005, 12: 289-298.